Welcome, Guest. Please login or register.
May 26, 2024, 10:43:28 am

Login with username, password and session length


Members
  • Total Members: 6309
  • Latest: Vicki
Stats
  • Total Posts: 55126
  • Total Topics: 4851
  • Online Today: 98
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 44
Total: 44

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: FDA Approves Merck's Zepatier for Genotypes 1 and 4  (Read 6858 times)

0 Members and 1 Guest are viewing this topic.

Offline gnatcatcher

  • Member
  • Posts: 1,372
FDA Approves Merck's Zepatier for Genotypes 1 and 4
« on: January 29, 2016, 06:28:46 pm »
9/29/71 transfusions
HCV genotype 1a
7/09/15-9/30/15 Harvoni

Before treatment:
Viral Load 9,490,582
FibroScan 19.5 kPa [F4]
ALT 262
AST 217
ALP 183

Most recent:
VL still UNDETECTED (SVR 102)
FibroScan 7.6 kPa [F1-2]
ALT 15
AST 20
ALP 85

Offline FutureThinker

  • Member
  • Posts: 711
  • Onward and upward!
Re: FDA Approves Merck's Zepatier for Genotypes 1 and 4
« Reply #1 on: January 30, 2016, 05:03:52 pm »
Just saw this news on Zepatier!! Also, for anyone who needs a dose of hope, go to Hepmag's homepage under "Most Viewed" on the right, and read the article, "2016 Hepatitis C drug Approval Outlook" dated 1-15-16.  THIS IS GOING TO BE THE YEAR FOR A LOT OF US!!!!!

***** A new and very important recommendation for treatment with this new drug is pre-treatment testing for NS5A polymorphisms.  I got into an argument with my doctor about the benefit of this before starting any of the available drugs for GT1 and he thought I was crazy........ there is going to be more specific testing done before any of these are prescribed in the very near future, IMHO. Thanks for posting, FT
Treatment naive
Likely contracted mid-70s
Diagnosed 1a, 2011
F1-2
Harvoni X 12 weeks, completed 5/17/16
Pre-treatment: VL 3 mil, AST 64, ALT 84
4 week labs: VL 30, AST 21, ALT 14
8 week labs: VL UD!!!, AST 22, ALT 16
12 week labs: VL UD, AST 23, ALT 14
2 wk EOT: VL UD
12 wk EOT: VL UD, AST 22, ALT 13 =  SVR 12! Yay! 
Last hep appointment: VL UD, AST 19, ALT 12 = SVR 39! I AM DONE!

 


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.